Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichiro Usuku

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|October 15, 2016
Web-Based Evaluation System to Measure Learning Effectiveness in Kampo MedicineNorio Iizuka, Koichiro Usuku, Hajime Nakae, et al.
Journal of the Neurological Sciences|April 27, 2005
ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individualsMineki Saito, Nobutaka Eiraku, Koichiro Usuku, et al.
Journal of Neuroimmunology|October 7, 2004
Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)Daisuke Kodama, Mineki Saito, Wataru Matsumoto, et al.
Diabetes Research and Clinical Practice|June 23, 2016
Combined arteriosclerotic assessment of ankle-brachial index and maximum intima-media thickness via CCTA is useful for predicting coronary artery stenosis in patients with type 2 diabetesAkira Yoshida, Hideaki Jinnouchi, Seigo Sugiyama, et al.
Journal of Neurovirology|August 1, 2006
Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus loadHirohisa Nose, Mineki Saito, Koichiro Usuku, et al.
The Journal of Infectious Diseases|January 1, 2004
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesisMineki Saito, Masanori Nakagawa, Shun Kaseda, et al.
The Journal of Infectious Diseases|January 15, 2008
Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptideHirohisa Nose, Ryuji Kubota, Nilufer P Seth, et al.
Blood|February 1, 2003
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriersMineki Saito, Veronique M Braud, Peter Goon, et al.
Retrovirology|September 21, 2006
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trialGraham P Taylor, Peter Goon, Yoshitaka Furukawa, et al.
Surgery Today|January 4, 2019
Long-term results of intersphincteric resection for low rectal cancer in JapanKazutaka Yamada, Yasumitsu Saiki, Shota Takano, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Evidence-Based Complementary and Alternative Medicine : Ecam|October 15, 2016
Web-Based Evaluation System to Measure Learning Effectiveness in Kampo MedicineNorio Iizuka, Koichiro Usuku, Hajime Nakae, et al.
Journal of the Neurological Sciences|April 27, 2005
ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individualsMineki Saito, Nobutaka Eiraku, Koichiro Usuku, et al.
Journal of Neuroimmunology|October 7, 2004
Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)Daisuke Kodama, Mineki Saito, Wataru Matsumoto, et al.
Diabetes Research and Clinical Practice|June 23, 2016
Combined arteriosclerotic assessment of ankle-brachial index and maximum intima-media thickness via CCTA is useful for predicting coronary artery stenosis in patients with type 2 diabetesAkira Yoshida, Hideaki Jinnouchi, Seigo Sugiyama, et al.
Journal of Neurovirology|August 1, 2006
Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus loadHirohisa Nose, Mineki Saito, Koichiro Usuku, et al.
The Journal of Infectious Diseases|January 1, 2004
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesisMineki Saito, Masanori Nakagawa, Shun Kaseda, et al.
The Journal of Infectious Diseases|January 15, 2008
Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptideHirohisa Nose, Ryuji Kubota, Nilufer P Seth, et al.
Blood|February 1, 2003
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriersMineki Saito, Veronique M Braud, Peter Goon, et al.
Retrovirology|September 21, 2006
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trialGraham P Taylor, Peter Goon, Yoshitaka Furukawa, et al.
Surgery Today|January 4, 2019
Long-term results of intersphincteric resection for low rectal cancer in JapanKazutaka Yamada, Yasumitsu Saiki, Shota Takano, et al.
Pageof 4